AGENUS INC Purchase Agreements
12 Contracts & Agreements
- Purchase and Sale Agreement, dated as of May 6, 2024, by and between Agenus Inc., Agenus Royalty Fund, LLC, Agenus Holdings 2024, LLC, and Ligand Pharmaceuticals Incorporated (Filed With SEC on August 8, 2024)
- Amendment No. 1 to Royalty Purchase Agreement, dated June 22, 2021, by and among Antigenics LLC, Healthcare Royalty Partners III, L.P. and certain of its affiliates (Filed With SEC on August 9, 2021)
- Royalty Purchase Agreement dated September 20, 2018, by and among Agenus Inc., Agenus Royalty Fund, LLC and XOMA (US) LLC (Filed With SEC on November 7, 2018)
- Royalty Purchase Agreement dated January 6, 2018, by and among Antigenics LLC, Healthcare Royalty Partners III, L.P. and certain of its affiliates (Filed With SEC on May 10, 2018)
- PURCHASE AGREEMENT, dated as of December 23, 2015 by and among AgenusInc., a Delaware corporation, as the Purchaser, PhosImmune Inc., a Virginia corporation, as the Company, the... (Filed With SEC on December 23, 2015)
- ASSET PURCHASE AGREEMENT by and between AGENUS INC., CELEXION, LLC and THE MEMBERS OF CELEXION dated as of April 7, 2015 ASSET PURCHASE AGREEMENT (Filed With SEC on April 8, 2015)
- SECURITIES PURCHASE AGREEMENT (as amended to date) (Filed With SEC on September 19, 2013)
- ANTIGENICS INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 5, 2009)
- ANTIGENICS INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 3, 2009)
- ANTIGENICS INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 10, 2008)
- ANTIGENICS INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 11, 2008)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 31, 2006)
